The company will leverage Verily's experience in miniaturized electronics, analytics, and consumer software development, with Sanofi's clinical expertise and experience in bringing innovative treatments to people living with diabetes
Read MoreWith India’s regulatory mechanism as weak as it is, the latest government advisory could end up being the pass to small-time players to push their subpar products into government hospitals under a competitive price tag
Read MoreMilk has been linked to cancer in various studies. And yet most Indians guzzle down milk indiscriminately. Watch your intake. Over the age of 18, you need some yoghurt a few times a week, no milk
Read MoreDelhi and parts of north India are facing a spike in chikungunya cases; this year about 10,000 suspected cases of the disease have been recorded in seven months
Read MoreChikungunya is a viral illness and its symptoms are similar to those of dengue, which include high-grade fever, severe joint pain, muscle pain and headache and joint swelling
Read MoreThe plant was sold to Frontida in June by Sun, India's No. 1 drugmaker, which said the move was 'a part of its manufacturing consolidation in the US'
Read MoreIt plans to offer preventive cardiology and diabetology in collaboration with Singapore-based Renew Group, eyes 100 clinics with 150 crore investment.
Read MoreUS Patent and Trade Mark Office’s decision to reject the patent claims of Teva Pharmaceutical Industries on its 40-milligram dosage of multiple sclerosis drug Copaxone is undoubtedly a booster dose for the generic drug industry and the Indian drug makers in particular
Read More